SCHEMBL4625875

SCHEMBL4625875

Cc1cccc(CNC(=N)/C=C/c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 4/20 0.50
▸ MMP2 P08253 4/20 0.50
▸ MMP9 P14780 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.48
▸ HPGD P15428 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ MAOB P27338 3/20 0.48
▸ MAOA P21397 2/20 0.48
▸ EGFR P00533 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ SENP1 Q9P0U3 3/20 0.45
▸ HDAC4 P56524 1/20 0.44
▸ MEF2D Q14814 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ ALOX12 P18054 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4626151 0.99 MMP1 (0.49) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL3029548 0.86 MMP1 (0.65) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL5082489 0.86 MMP1 (0.65) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL4624960 0.85 MMP1 (0.53) MMP1MMP2MMP9ALDH1A1HPGD
Hydrochloric Acid SCHEMBL4626102 0.85 MMP1 (0.63) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL7045476 0.84 GRIN1 (0.54) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL4626300 0.84 GRIN1 (0.54) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL4627821 0.84 SENP1 (0.50) MMP1MMP2MMP9ALDH1A1LMNA
SCHEMBL4626177 0.84 MMP1 (0.49) MMP1MMP2MMP9ALDH1A1HPGD
SCHEMBL7046499 0.84 SENP1 (0.50) MMP1MMP2MMP9ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296940-B1 AMIDINE DERIVATIVES AS SELECTIVE ANTAGONISTS OF NMDA RECEPTORS MERCK SHARP & DOHME (GB) 2008-07-02 — — EP claimed
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors CURTIS NEIL ROY (GB) 2003-06-26 — — US claimed
EP-1296940-B1 AMIDINE DERIVATIVES AS SELECTIVE ANTAGONISTS OF NMDA RECEPTORS MERCK SHARP & DOHME (GB) 2008-07-02 — — EP disclosed
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors CURTIS NEIL ROY (GB) 2003-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors GRIN1, GRIN2A, GRM1 MMP1 4724/4885MMP2 4144/4885MMP9 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback